Some patients may tolerate one medication better than the other based on their unique physiology or previous experiences with similar treatments
doi:10.1155/2015/806979 Epub 2015 May 17
Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
2,97 The EFSA also states that B12 has not been found to be carcinogenic or mutagenic in in vitro and in vivo studies
He doesnt charge by the hour
While insurance companies may not cover every indication (i.e., medical reason to take a drug), doctors are increasingly prescribing GLP-1s to a wider array of people with health concerns tied to carrying around excess weight, including joint pain, inflammation, and high blood pressure
)
